Method for treating cancer harboring EGFR mutations

Details for Australian Patent Application No. 2007299080 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Solca, Flavio

Agent Davies Collison Cave

Pub. Number AU-A-2007299080

PCT Pub. Number WO2008/034776

Priority 06120856.7 18.09.06 EP; 07101505.1 31.01.07 EP

Filing date 14 September 2007

Wipo publication date 27 March 2008

International Classifications

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

7 May 2009 PCT application entered the National Phase

  PCT publication WO2008/034776 Priority application(s): WO2008/034776

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007299081-A process for the manufacture of carbon disulphide

2007299043-Expansion method for adult stem cells from blood, particularly peripheral blood, and relative application in medical field